Hemangiosarcoma - 25 Studies Found
Recruiting |
: Doxorubicin With Upfront Dexrazoxane Plus Olaratumab for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma :
|
Recruiting |
: Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma :
: |
Completed |
: Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma :
: |
Completed |
: Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma :
: Drug: romidepsin DEP is administered at a dose of 13 mg/m2 as a 4-hour intravenous infusion in the outpa |
Active, not recruiting |
: Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma :
: |